YMTX Insider Trading Activity and SEC Form 4 Filings
YMTX insider trading summary
No open-market insider purchases or sales of Yumanity Therapeutics, Inc. (YMTX) have been reported on SEC Form 4 in the past 12 months.
Latest YMTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 2, 2022 | Marie Epstein | Principal Accounting Officer | Sell | $3K (1,976 @ $1.69) |
| Dec 2, 2022 | Devin Whittemore Smith | SVP and General Counsel | Sell | $5K (3,116 @ $1.69) |
| Dec 2, 2022 | Michael D Wyzga | See Remarks | Sell | $5K (3,116 @ $1.69) |
| Dec 2, 2022 | Richard Peters | President and CEO | Sell | $18K (10,890 @ $1.69) |
| Jul 5, 2022 | Richard Peters | President and CEO | Sell | $8K (4,584 @ $1.85) |
| Jun 3, 2022 | Devin Whittemore Smith | SVP and General Counsel | Sell | $3K (2,923 @ $1.19) |
| Jun 3, 2022 | Michael D Wyzga | See Remarks | Sell | $3K (2,887 @ $1.19) |
| Jun 3, 2022 | Marie Epstein | Principal Accounting Officer | Sell | $2K (1,806 @ $1.19) |
| Jun 3, 2022 | Richard Peters | President and CEO | Sell | $12K (10,206 @ $1.19) |
| Mar 28, 2022 | Richard Peters | President and CEO | Sell | $20K (10,715 @ $1.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.